Synonym
Domperidone monomaleate; Domperidone; Motilium; Domperidona; KW 5338; KW5338; KW-5338; NSC 299589; NSC299589; NSC-299589; R33812; R-33812; R 33812
IUPAC/Chemical Name
5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one maleate
InChi Key
OAUUYDZHCOULIO-BTJKTKAUSA-N
InChi Code
InChI=1S/C22H24ClN5O2.C4H4O4/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29;5-3(6)1-2-4(7)8/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30);1-2H,(H,5,6)(H,7,8)/b;2-1-
SMILES Code
O=C(O)/C=C\C(O)=O.O=C1NC2=CC(Cl)=CC=C2N1C3CCN(CCCN4C5=CC=CC=C5NC4=O)CC3
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
541.99
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Buffery PJ, Strother RM. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. N Z Med J. 2015 Jun 12;128(1416):66-74. Review. PubMed PMID: 26117678.
2: Marzi M, Weitz D, Avila A, Molina G, Caraballo L, Piskulic L. [Cardiac adverse effects of domperidone in adult patients: a systematic review]. Rev Med Chil. 2015 Jan;143(1):14-21. doi: 10.4067/S0034-98872015000100002. Review. Spanish. PubMed PMID: 25860264.
3: Makari J, Cameron K, Battistella M. Domperidone-associated sudden cardiac death in the general population and implications for use in patients undergoing hemodialysis: a literature review. Can J Hosp Pharm. 2014 Nov;67(6):441-6. Review. PubMed PMID: 25548402; PubMed Central PMCID: PMC4275141.
4: Phan H, DeReese A, Day AJ, Carvalho M. The dual role of domperidone in gastroparesis and lactation. Int J Pharm Compd. 2014 May-Jun;18(3):203-7. Review. PubMed PMID: 25306766.
5: Doggrell SA, Hancox JC. Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. Expert Opin Drug Saf. 2014 Jan;13(1):131-8. doi: 10.1517/14740338.2014.851193. Epub 2013 Oct 23. Review. PubMed PMID: 24147629.
6: Hondeghem LM. Domperidone: limited benefits with significant risk for sudden cardiac death. J Cardiovasc Pharmacol. 2013 Mar;61(3):218-25. doi: 10.1097/FJC.0b013e31827afd0d. Review. PubMed PMID: 23188128.
7: van Roeden SE, Belle-van Meerkerk G, van Tuyl SA, van de Ree MA, Muller AF. [Domperidone and the risk of sudden cardiac death]. Ned Tijdschr Geneeskd. 2013;157(45):A6770. Review. Dutch. PubMed PMID: 24191928.
8: Scott B. Question 2. How effective is domperidone at reducing symptoms of gastro-oesophageal reflux in infants? Arch Dis Child. 2012 Aug;97(8):752-5. doi: 10.1136/archdischild-2012-302183. Review. PubMed PMID: 22859430.
9: Rossi M, Giorgi G. Domperidone and long QT syndrome. Curr Drug Saf. 2010 Jul 2;5(3):257-62. Review. PubMed PMID: 20394569.
10: Sugumar A, Singh A, Pasricha PJ. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2008 Jul;6(7):726-33. doi: 10.1016/j.cgh.2008.02.065. Epub 2008 Jun 4. Review. PubMed PMID: 18524689.
11: Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007 Sep;102(9):2036-45. Epub 2007 May 3. Review. PubMed PMID: 17488253.
12: Ahmad N, Keith-Ferris J, Gooden E, Abell T. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol. 2006 Dec;6(6):571-6. Epub 2006 Sep 25. Review. PubMed PMID: 16997628.
13: Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol. 2005 Jun;59(6):725-9. Review. PubMed PMID: 15948939; PubMed Central PMCID: PMC1884866.
14: Henderson A. Domperidone. Discovering new choices for lactating mothers. AWHONN Lifelines. 2003 Feb-Mar;7(1):54-60. Review. PubMed PMID: 12674062.
15: Prakash A, Wagstaff AJ. Domperidone. A review of its use in diabetic gastropathy. Drugs. 1998 Sep;56(3):429-45. Review. PubMed PMID: 9777316.
16: Zapata P, Iturriaga R, Larraín C. Domperidone as a tool to assess the role of dopamine within carotid body chemoreception. Adv Exp Med Biol. 1996;410:291-7. Review. PubMed PMID: 9030314.
17: Brown CK, Khanderia U. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Clin Pharm. 1990 May;9(5):357-65. Review. PubMed PMID: 2190745.
18: Cherian S, Sachdev HP, Puri RK. Domperidone. Indian Pediatr. 1989 Sep;26(9):932-5. Review. PubMed PMID: 2699318.
19: Champion MC. Domperidone. Gen Pharmacol. 1988;19(4):499-505. Review. PubMed PMID: 3044918.
20: Champion MC, Hartnett M, Yen M. Domperidone, a new dopamine antagonist. CMAJ. 1986 Sep 1;135(5):457-61. Review. PubMed PMID: 3527396; PubMed Central PMCID: PMC1491526.
